Security Snapshot

HEALTHEQUITY, INC. - Common Stock (HQY) Institutional Ownership

CUSIP: 42226A107

13F Institutional Holders and Ownership History from Q3 2014 to Q2 2026

Latest Period

Q2 2026

Institutions Reporting

493

Shares (Excl. Options)

89,591,948

Price

$90.32

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0.01%
Share change
+3,495,019
Value change
+$338,990,077
Number of holders
493
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
83,763,988
SEC-reported price per share
$100.99
Insider filing price
$100.99
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • HQY - HEALTHEQUITY, INC. - Common Stock is tracked under CUSIP 42226A107.
  • 493 institutions reported positions in Q2 2026.
  • 4 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 484 to 493 between Q1 2026 and Q2 2026.
  • SEC-reported value moved from $7,205,435,758 to $8,084,340,799.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 493 institutions filings for Q2 2026.

Open SEC evidence

Security key

42226A107

Latest holder period

Q2 2026

13F holders

493

13D/G owners

4

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
4
Security
HQY
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
WASATCH ADVISORS LP 9.5% $719,013,585 7,960,735 Wasatch Advisors LP 30 Jun 2026
VANGUARD CAPITAL MANAGEMENT LLC 5.3% $374,324,237 4,479,170 Vanguard Capital Management 31 Mar 2026
VANGUARD PORTFOLIO MANAGEMENT LLC 4.9% -1.4% $391,987,151 -$9,372,397 4,137,941 -2.3% Vanguard Portfolio Management 30 Jun 2026
FMR LLC 4.1% $330,726,570 3,489,781 FMR LLC 30 Sep 2025

As of 30 Jun 2026, 493 institutional investors reported holding 89,591,948 shares of HEALTHEQUITY, INC. - Common Stock (HQY). This represents 107% of the company’s total 83,763,988 outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
71%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 13% 11,277,914 +7.1% 0.02% $1,018,621,255
WASATCH ADVISORS LP 9.5% 7,960,735 +11% 4.7% $719,013,585
MORGAN STANLEY 5.4% 4,547,218 +83% 0.02% $410,704,829
VANGUARD PORTFOLIO MANAGEMENT LLC 4.8% 4,057,643 -2.5% 0.02% $366,486,316
VANGUARD CAPITAL MANAGEMENT LLC 4.3% 3,640,776 -4.8% 0.01% $328,834,888
STATE STREET CORP 3.9% 3,241,046 +4.6% 0.01% $292,717,061
GEODE CAPITAL MANAGEMENT, LLC 2.8% 2,374,467 +5.1% 0.01% $214,497,588
AQR CAPITAL MANAGEMENT LLC 2.4% 1,999,209 -4.4% 0.06% $176,050,345
DIMENSIONAL FUND ADVISORS LP 2.2% 1,869,036 +15% 0.03% $168,794,190
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 2.1% 1,773,227 +6.8% 0.48% $160,157,863
FMR LLC 1.8% 1,538,387 +36% 0.01% $138,947,073
BROWN ADVISORY INC 1.6% 1,372,624 -2.8% 0.19% $123,975,449
Clearbridge Investments, LLC 1.5% 1,296,765 -1% 0.1% $117,123,775
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1.4% 1,188,902 +1.2% 0.01% $107,381,628
Greenhouse Funds LLLP 1.4% 1,183,024 -5.9% 5.6% $106,850,728
JPMORGAN CHASE & CO 1.4% 1,158,837 -2.1% 0.01% $102,097,653
GENEVA CAPITAL MANAGEMENT LLC 1.4% 1,149,680 -2.1% 2.4% $103,839,080
BANK OF AMERICA CORP /DE/ 1.4% 1,146,735 +33% 0.01% $103,573,112
DAVENPORT & Co LLC 1.3% 1,087,218 +7.1% 0.5% $98,197,530
NORTHERN TRUST CORP 1.3% 1,072,119 +3.5% 0.01% $96,833,789
GOLDMAN SACHS GROUP INC 1.2% 1,007,434 +26% 0.01% $90,991,438
PRICE T ROWE ASSOCIATES INC /MD/ 1.2% 994,551 +24% 0.01% $89,829,000
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 1.2% 965,807 +34629% 0.04% $87,231,688
Atalan Capital Partners, LP 1.1% 915,270 +3.6% 5.1% $82,667,186
LOOMIS SAYLES & CO L P 1.1% 908,554 -2.5% 0.1% $82,060,598

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
48
Latest
Q2 2026
Rows shown
1-25 of 48
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q2 89,591,948 $8,084,340,799 +$338,990,077 $90.32 493
2026 Q1 86,281,312 $7,205,435,758 -$234,304,625 $83.57 484
2025 Q4 89,097,853 $8,162,571,554 +$470,046 $91.61 511
2025 Q3 88,488,719 $8,382,485,204 -$281,039,998 $94.77 488
2025 Q2 91,265,687 $9,558,076,192 -$62,139,841 $104.76 482
2025 Q1 92,165,244 $8,128,508,816 +$152,545,171 $88.37 459
2024 Q4 90,161,222 $8,653,352,575 +$170,175,956 $95.95 440
2024 Q3 88,358,980 $7,240,539,201 -$1,337,258 $81.85 401
2024 Q2 87,933,863 $7,578,890,500 +$125,440,183 $86.20 383
2024 Q1 86,440,231 $7,055,956,398 +$115,959,986 $81.63 363
2023 Q4 85,288,872 $5,655,435,507 -$174,634,686 $66.30 346
2023 Q3 87,732,717 $6,409,147,459 +$222,841,176 $73.05 341
2023 Q2 84,708,035 $5,345,679,594 -$18,798,092 $63.14 314
2023 Q1 84,947,616 $4,987,032,360 +$94,905,209 $58.71 307
2022 Q4 83,488,262 $5,144,359,254 -$152,630,765 $61.64 319
2022 Q3 85,786,896 $5,763,609,886 +$105,104,438 $67.17 299
2022 Q2 83,615,213 $5,132,344,951 +$14,846,792 $61.39 297
2022 Q1 83,664,137 $5,635,991,272 +$177,196,612 $67.44 288
2021 Q4 81,505,488 $3,607,007,806 -$76,931,586 $44.24 270
2021 Q3 80,796,713 $5,232,496,642 -$283,262,504 $64.76 280
2021 Q2 84,185,968 $6,774,579,492 +$154,343,182 $80.48 281
2021 Q1 82,527,536 $5,613,882,784 +$216,959,708 $68.00 281
2020 Q4 79,339,982 $5,533,688,719 +$175,728,462 $69.71 276
2020 Q3 76,929,228 $3,949,320,592 +$319,809,436 $51.37 273
2020 Q2 70,448,985 $4,130,042,190 +$45,790,946 $58.67 287
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .